Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Systemic Inflammatory Response Syndrome Treatment Market


4. Market Overview

4.1. Introduction

4.1.1. Indication Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecasts, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis


5. Market Outlook

5.1. Technological Advancements

5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Launch & Approvals, etc.)

5.3. Regulatory Scenario, by Region/Country

5.4. Pipeline Analysis

5.5. Key product/brand Analysis


6. Global Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecasts, by Indication

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Indication, 2017–2027

6.3.1. Meningitis

6.3.2. Urinary Tract Infection (UTI)

6.3.3. Pneumonia

6.3.4. Hemorrhage

6.3.5. Autoimmune Diseases

6.3.6. Others

6.4. Market Attractiveness, by Indication


7. Global Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecasts, by End-user

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by End-user, 2017–2027

7.3.1. Hospital & Ambulatory Surgical Centers

7.3.2. Specialty Clinics

7.3.3. Others

7.4. Market Attractiveness, by End-user


8. Global Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecasts, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness, by Country/Region


9. North America Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Market Value Forecast, by Indication, 2017–2027

9.2.1. Meningitis

9.2.2. Urinary Tract Infection (UTI)

9.2.3. Pneumonia

9.2.4. Hemorrhage

9.2.5. Autoimmune Diseases

9.2.6. Others

9.3. Market Value Forecast, by End-user, 2017–2027

9.3.1. Hospital & Ambulatory Surgical Centers

9.3.2. Specialty Clinics

9.3.3. Others

9.4. Market Value Forecast, by Country, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Indication

9.5.2. By End-user

9.5.3. By Country


10. Europe Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Indication, 2017–2027

10.2.1. Meningitis

10.2.2. Urinary Tract Infection (UTI)

10.2.3. Pneumonia

10.2.4. Hemorrhage

10.2.5. Autoimmune Diseases

10.2.6. Others

10.3. Market Value Forecast, by End-user, 2017–2027

10.3.1. Hospital & Ambulatory Surgical Centers

10.3.2. Specialty Clinics

10.3.3. Others

10.4. Market Value Forecast, by Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Russia

10.4.7. Rest of Europe

10.5. Market Attractiveness Analysis

10.5.1. By Indication

10.5.2. By End-user

10.5.3. By Country/Sub-region


11. Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Indication, 2017–2027

11.2.1. Meningitis

11.2.2. Urinary Tract Infection (UTI)

11.2.3. Pneumonia

11.2.4. Hemorrhage

11.2.5. Autoimmune Diseases

11.2.6. Others

11.3. Market Value Forecast, by End-user, 2017–2027

11.3.1. Hospital & Ambulatory Surgical Centers

11.3.2. Specialty Clinics

11.3.3. Others

11.4. Market Value Forecast, by Country/Sub-region, 2017–2027

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Market Attractiveness Analysis

11.5.1. By Indication

11.5.2. By End-user

11.5.3. By Country/Sub-region


12. Latin America Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Indication, 2017–2027

12.2.1. Meningitis

12.2.2. Urinary Tract Infection (UTI)

12.2.3. Pneumonia

12.2.4. Hemorrhage

12.2.5. Autoimmune Diseases

12.2.6. Others

12.3. Market Value Forecast, by End-user, 2017–2027

12.3.1. Hospital & Ambulatory Surgical Centers

12.3.2. Specialty Clinics

12.3.3. Others

12.4. Market Value Forecast, by Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Market Attractiveness Analysis

12.5.1. By Indication

12.5.2. By End-user

12.5.3. By Country/Sub-region

13. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Indication, 2017–2027

13.2.1. Meningitis

13.2.2. Urinary Tract Infection (UTI)

13.2.3. Pneumonia

13.2.4. Hemorrhage

13.2.5. Autoimmune Diseases

13.2.6. Others

13.3. Market Value Forecast, by End-user, 2017–2027

13.3.1. Hospital & Ambulatory Surgical Centers

13.3.2. Specialty Clinics

13.3.3. Others

13.4. Market Value Forecast, by Country/Sub-region, 2017–2027

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Israel

13.4.4. Rest of Middle East & Africa

13.5. Market Attractiveness Analysis

13.5.1. By Indication

13.5.2. By End-user

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player - Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis, by Company, 2018

14.3. Company Profiles

14.3.1. CytoSorbents Corporation

14.3.1.1. Overview (HQ, Employee Strength, Business Segments)

14.3.1.2. Financials

14.3.1.3. Recent Developments

14.3.1.4. Strategy

14.3.2. RegeneRx Biopharmaceuticals, Inc.

14.3.2.1. Overview (HQ, Employee Strength, Business Segments)

14.3.2.2. Financials

14.3.2.3. Recent Developments

14.3.2.4. Strategy

14.3.3. Endacea, Inc.

14.3.3.1. Overview (HQ, Employee Strength, Business Segments)

14.3.3.2. Strategy

14.3.4. Adrenomed AG

14.3.4.1. Overview (HQ, Employee Strength, Business Segments)

14.3.4.2. Recent Developments

14.3.4.3. Strategy

14.3.5. GlaxoSmithKline plc

14.3.5.1. Overview (HQ, Employee Strength, Business Segments)

14.3.5.2. Financials

14.3.5.3. Recent Developments

14.3.5.4. Strategy

14.3.6. Asahi Kasei Corporation

14.3.6.1. Overview (HQ, Employee Strength, Business Segments)

14.3.6.2. Financials

14.3.6.3. Recent Developments

14.3.6.4. Strategy

14.3.7. Cardinal Health

14.3.7.1. Overview (HQ, Employee Strength, Business Segments)

14.3.7.2. Financials

14.3.7.3. Recent Developments

14.3.7.4. Strategy

14.3.8. Smith & Nephew plc

14.3.8.1. Overview (HQ, Employee Strength, Business Segments)

14.3.8.2. Financials

14.3.8.3. Recent Developments

14.3.8.4. Strategy

14.3.9. ConvaTec, Inc.

14.3.9.1. Overview (HQ, Employee Strength, Business Segments)

14.3.9.2. Financials

14.3.9.3. Recent Developments

14.3.9.4. Strategy

14.3.10. AstraZeneca

14.3.10.1. Overview (HQ, Employee Strength, Business Segments)

14.3.10.2. Financials

14.3.10.3. Recent Developments

14.3.10.4. Strategy

14.3.11. Orion Corporation

14.3.11.1. Overview (HQ, Employee Strength, Business Segments)

14.3.11.2. Financials

14.3.11.3. Recent Developments

14.3.11.4. Strategy

14.3.12. CHIESI Farmaceutici S.p.A.

14.3.12.1. Overview (HQ, Employee Strength, Business Segments)

14.3.12.2. Financials

14.3.12.3. Recent Developments

14.3.12.4. Strategy

14.3.13. Mylan N.V.

14.3.13.1. Overview (HQ, Employee Strength, Business Segments)

14.3.13.2. Financials

14.3.13.3. Recent Developments

14.3.13.4. Strategy

*Note: Financial details of companies that do not report this information in public domain might not have been captured



List of Figures



Figure 1 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn), by Indication, 2018

Figure 2 Global Systemic Inflammatory Response Syndrome Treatment Market Share, Top Trends, by Indication, 2018

Figure 3 Global Systemic Inflammatory Response Syndrome Treatment Market Share, by Region, 2018

Figure 4 Global Systemic Inflammatory Response Syndrome Treatment Market Share Analysis, by Region

Figure 5 Porter’s Five Forces Analysis

Figure 6 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) and Forecast, 2019–2027

Figure 7 Global Systemic Inflammatory Response Syndrome Treatment Market Value Share, by Indication, 2018

Figure 8 Global Systemic Inflammatory Response Syndrome Treatment Market Value Share, by End-user, 2018

Figure 9 Global Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 10 Global Systemic Inflammatory Response Syndrome Market Value (US$ Mn) and Y-o-Y Growth (%), by Meningitis, 2017–2027

Figure 11 Global Systemic Inflammatory Response Syndrome Market Value (US$ Mn) and Y-o-Y Growth (%), by Urinary Tract Infection (UTI), 2017–2027

Figure 12 Global Systemic Inflammatory Response Syndrome Market Value (US$ Mn) and Y-o-Y Growth (%), by Pneumonia, 2017–2027

Figure 13 Global Systemic Inflammatory Response Syndrome Market Value (US$ Mn) and Y-o-Y Growth (%), by Hemorrhage, 2017–2027

Figure 14 Global Systemic Inflammatory Response Syndrome Market Value (US$ Mn) and Y-o-Y Growth (%), by Autoimmune Diseases, 2017–2027

Figure 15 Global Systemic Inflammatory Response Syndrome Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 16 Global Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Indication, 2019–2027

Figure 17 Global Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 18 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), Hospitals & Ambulatory Surgical Centers, 2017–2027

Figure 19 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027

Figure 20 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 21 Global Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by End-user, 2019–2027

Figure 22 Global Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Region, 2018 and 2027

Figure 23 Global Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 24 North America Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 25 North America Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Country, 2019–2027

Figure 26 North America Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 27 North America Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 28 North America Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 29 North America Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Indication, 2019–2027

Figure 30 North America Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by End-user, 2019–2027

Figure 31 Europe Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 32 Europe Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 33 Europe Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 34 Europe Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 35 Europe Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 36 Europe Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Indication, 2019–2027

Figure 37 Europe Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by End-user, 2019–2027

Figure 38 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 39 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2027

Figure 40 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 41 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 42 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 43 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Indication, 2018-2027

Figure 44 Asia Pacific Europe Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by End-user, 2019–2027

Figure 45 Latin America Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 46 Latin America Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 47 Latin America Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 48 Latin America Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 49 Latin America Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 50 Latin America Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Indication, 2019–2027

Figure 51 Latin America Europe Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by End-user, 2019–2027

Figure 52 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 53 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

Figure 54 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 55 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 56 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 57 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by Indication, 2019–2027

Figure 58 Middle East & Africa Europe Systemic Inflammatory Response Syndrome Treatment Market Attractiveness Analysis, by End-user, 2019–2027

Figure 59 CytoSorbents Corporation R&D Expense (US$ Mn), 2016–2018

Figure 60 CytoSorbents Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 61 CytoSorbents Corporation Breakdown of Net Sales, by Region, 2018

Figure 62 RegeneRx Biopharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2018

Figure 63 RegeneRx Biopharmaceuticals, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2018

Figure 64 GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 65 GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018

Figure 66 GlaxoSmithKline plc Breakdown of Net Sales (%), by Geography, 2018

Figure 67 GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 68 Asahi Kasei Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

Figure 69 Asahi Kasei Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 70 Asahi Kasei Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Figure 71 Cardinal Health Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2019

Figure 72 Cardinal Health Medical Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 73 Smith & Nephew plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 74 Smith & Nephew plc R&D Expenses (US$ Mn), 2015–2018

Figure 75 Smith & Nephew plc Breakdown of Net Sales (%), by Region, 2018

Figure 76 Smith & Nephew plc Breakdown of Net Sales (%), by Business Segment, Advanced Wound Devices, 2018

Figure 77 ConvaTec, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 78 ConvaTec, Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 79 ConvaTec, Inc. Breakdown of Net Sales (%), by Business Segments, 2018

Figure 80 AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 81 AstraZeneca Breakdown of Net Sales (%), by Region, 2018

Figure 82 AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 83 AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018

Figure 84 Orion Corporation Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 85 Orion Corporation Breakdown of Net Sales (%), by Geography, 2018

Figure 86 Orion Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 87 Orion Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Figure 88 CHIESI Farmaceutici S.p.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 89 CHIESI Farmaceutici S.p.A. Breakdown of Net Sales (%), by Geography, 2018

Figure 90 CHIESI Farmaceutici S.p.A. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 91 CHIESI Farmaceutici S.p.A. Breakdown of Net Sales (%), by Therapeutic Area (Business Segment), 2018

Figure 92 Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 93 Mylan N.V. R&D Expenses (US$ Mn), 2017 and 2018

Figure 94 Mylan N.V. Breakdown of Net Sales, by Geography, 2018


List of Tables



Table 1Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 2 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 3 Global Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 4 North America Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 5 North America Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 6 North America Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 7 Europe Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 8 Europe Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 9 Europe Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–202

Table 11 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size (US$ Mn) Forecast, by Indication, 2017–2027

Table 13 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2027

Table 14 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 16 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 17 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18 Asia Pacific Systemic Inflammatory Response Syndrome Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027